Breakthroughs with medications that block fat absorption in the body sparked another weight-loss-drug craze in the early 2000s
The growing recognition of obesity as a treatable condition by payers and governments is bolstering demand
02 Apoyo de Fuerza Asociado con un mejor rendimiento y capacidad muscular
in the 2021 survey from GI Society, 91% of respondents reported comorbidities such as arthritis (51%), hypertension (33%), sleep apnea (30%), gastroesophageal reflux disease (29%), irritable bowel syndrome (29%), high cholesterol (25%), and diabetes (24%)
Throughout the day, you are not going to feel hungry, you are going to have to make a conscious decision to eat
Then, in 2015, came the SGLT2 inhibitors, with a demonstration of the formidable effects on cardiovascular risk with those